Vaxxinity, Inc.
Vaxxinity, Inc. (VAXX) Stock Overview
Explore Vaxxinity, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
63.4K
P/E Ratio
-1.11
EPS (TTM)
$-0.05
ROE
-0.00%
VAXX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Vaxxinity, Inc. (VAXX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 48.19, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.11 and a market capitalization of 63.4K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.